Heron Therapeutics, Inc. (HRTX) Stock Price

HRTXStock
$0.3276.94%52W
Market Cap$61.34M
P/E
PEG Ratio
Div yield
Beta1.66

HRTX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-84.57%
Price vs S&P 500 (4W)-36.62%
VGM Score38.36

HRTX Earnings Surprise History

Q2 25-0.02est. -0.01
Q3 25-0.10est. -0.01
Q4 25-0.02est. -0.03
Q1 26-0.04est. -0.02
Q2 26-0.03est. -0.02

HRTX Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.11
4.11
4.00
4.00

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
HRTXHeron Therapeutics, Inc.
CCD$0.32
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Heron Therapeutics, Inc.

Heron Therapeutics is a commercial-stage biopharmaceutical company with a portfolio of marketed products including APONVIE, SUSTOL, ZYNRELEF, and CINVANTI. The company develops innovative treatments to address unmet patient needs.